We are excited to announce that RTNN’s Dr. David Berube will serve as a member on the Risk Communication Advisory Committee for the Food and Drug Administration (FDA) beginning this October and spanning into the next administration. As a committee member, Dr. Berube will advise the FDA Commissioner on strategies to effectively communicate the risks and benefits of FDA-regulated products to the public. The committee is also tasked with reviewing and evaluating relevant research and facilitating the implementation of public communication programs.